Ayala Pharmaceuticals, Inc. Quarterly Lessee, Operating Lease, Liability, Undiscounted Excess Amount in USD from Q4 2019 to Q4 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.
Summary
Ayala Pharmaceuticals, Inc. quarterly Lessee, Operating Lease, Liability, Undiscounted Excess Amount history and growth rate from Q4 2019 to Q4 2023.
  • Ayala Pharmaceuticals, Inc. Lessee, Operating Lease, Liability, Undiscounted Excess Amount for the quarter ending December 31, 2023 was $5K.
Lessee, Operating Lease, Liability, Undiscounted Excess Amount, Quarterly (USD)
Lessee, Operating Lease, Liability, Undiscounted Excess Amount, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2023 $5K Dec 31, 2023 10-K 2024-04-16
Q3 2023 $459K +$458K +45800% Sep 30, 2023 10-Q 2023-11-20
Q2 2023 $408K +$407K +40700% Jun 30, 2023 10-Q 2023-08-10
Q1 2023 $337K +$336K +33600% Mar 31, 2023 10-Q 2023-05-23
Q3 2022 $1K $0 0% Oct 31, 2022 10-K 2023-02-10
Q2 2022 $1K Jul 31, 2022 10-Q 2022-09-13
Q1 2022 $1K Apr 30, 2022 10-Q 2022-06-08
Q4 2021 $1K -$952K -99.9% Jan 31, 2022 10-Q 2022-03-17
Q3 2021 $1K -$1.05M -99.9% Oct 31, 2021 10-K 2022-02-14
Q4 2020 $953K -$400K -29.6% Jan 31, 2021 10-Q 2021-03-16
Q3 2020 $1.05M Oct 31, 2020 10-K 2021-01-22
Q2 2020 $1.15M Jul 31, 2020 10-Q 2020-09-10
Q1 2020 $1.25M Apr 30, 2020 10-Q 2020-06-11
Q4 2019 $1.35M Jan 31, 2020 10-Q 2020-03-13
* An asterisk sign (*) next to the value indicates that the value is likely invalid.